Free tool
FAERS Monitor: Esmolol Hydrochloride Double Strength In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 205703 or its brand name (Esmolol Hydrochloride Double Strength In Plastic Container, Esmolol Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
115
Serious
104
90% of reports
Hospitalization
43
Death reported
17
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective22
- product use issue15
- product use in unapproved indication12
- cardiac arrest7
- condition aggravated6
- drug ineffective for unapproved indication6
- hepatotoxicity6
- hyperbilirubinaemia6
- hypotension6
- cardiogenic shock5
- hepatomegaly5
- hypertension5
- overdose5
- renal failure5
- respiratory arrest5
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2009 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 7 |
| 2019 | 12 |
| 2020 | 5 |
| 2021 | 13 |
| 2022 | 9 |
| 2023 | 18 |
| 2024 | 7 |
| 2025 | 22 |
| 2026 | 7 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,044 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hyperbilirubinaemiaSignal | 6 | 106.0 | 48.6 | 523 |
| hepatomegalySignal | 5 | 93.1 | 39.5 | 368 |
| cardiogenic shockSignal | 5 | 63.7 | 27.0 | 249 |
| hepatotoxicitySignal | 6 | 49.3 | 22.6 | 238 |
| respiratory arrestSignal | 5 | 33.2 | 14.1 | 126 |
| drug ineffective for unapproved indicationSignal | 6 | 20.0 | 9.2 | 90 |
| cardiac arrestSignal | 7 | 15.5 | 7.6 | 81 |
| product use issueSignal | 15 | 14.6 | 9.1 | 178 |
| product use in unapproved indicationSignal | 12 | 8.9 | 5.2 | 77 |
| renal failureSignal | 5 | 6.9 | 2.9 | 20 |
| hypotensionSignal | 6 | 5.5 | 2.5 | 18 |
| hypertensionSignal | 5 | 4.3 | 1.8 | 10 |
| overdoseSignal | 5 | 4.2 | 1.8 | 9 |
| condition aggravatedSignal | 6 | 3.6 | 1.7 | 9 |
| drug ineffectiveSignal | 22 | 3.1 | 2.1 | 30 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.